News Category
Global pediatric stroke deaths and disability have declined since 1990, but adolescent incidence and hemorrhagic stroke mortality in low-SDI regions a...
Kairos Pharma received the 2026 Biotech Breakthrough Award for its investigational therapy ENV-105, which aims to overcome treatment resistance in met...
A mouse study finds that an aqueous extract of Phyllanthus urinaria L reduces cisplatin-induced acute kidney injury by curbing inflammation, apoptosis...
Heidelberg Pharma will present new clinical data on its ATAC candidates, pamlectabart tismanitin (HDP-101) and HDP-102, at the 68th ASH Annual Meeting...
A new expert consensus published in World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical decision-making for unilate...
Sequencio Therapeutics will present new preclinical data at SITC 2026 showing its lead cancer vaccine candidates generated targeted immune responses a...
Kairos Pharma's ENV-105 doubled median progression-free survival in metastatic castration-resistant prostate cancer, potentially overcoming treatment ...
University of Virginia researchers have developed an experimental ultrasound-based technique to deliver therapeutic nanoparticles into the brain to fi...
A new expert consensus published in World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical management of unilateral Wi...
A Mayo Clinic study has found that cerebrospinal fluid contains DNA from complex brain tumors, potentially enabling less invasive diagnosis and monito...
New research shows rural residents face a nearly threefold higher risk of dying from a heart attack before reaching a hospital, highlighting critical ...
A new analysis raises the annual U.S. nonmelanoma skin cancer estimate to 4.7 million, highlighting underreporting and the need for better tracking an...
VERAXA Biotech is expanding its use of New Approach Methodologies (NAMs) to improve the clinical relevance of its antibody-based cancer therapies whil...
A dual-targeting antibody demonstrated profound effects in mice across multiple tumor types, offering a potential path to broaden the reach of cancer ...
TransCode Therapeutics has launched a formal strategic review to explore options for maximizing value, including potential licensing, partnerships, or...
A Phase 3 trial shows that combining two immunotherapy drugs significantly extends survival in patients with a deadly form of lung cancer, potentially...
VolitionRx's letter of intent with Missionpharma aims to develop and commercialize a low-cost NETosis diagnostic test, initially targeting neonatal se...
The American Heart Association's Support Network provides free online emotional support and shared experiences for patients, survivors, and caregivers...
Creative Biolabs is promoting its tumor organoid and immune cell co-culture services, including CAR-T models, to provide more physiologically relevant...
Creative Biolabs has launched an integrated OMV and exosome-boosted CAR-T development platform to help researchers address poor infiltration, immunosu...
TransCode Therapeutics announced that its Phase 1a trial of TTX-MC138 met its primary safety endpoint with no dose-limiting toxicities and showed dise...
Oncotelic Therapeutics published a peer-reviewed study showing its PDAOAI platform identified a four-gene prognostic signature in hepatocellular carci...
Coherence Neuro's $45 million Series A, backed by Peter Thiel and OpenAI, will fund first-in-human trials of its SOMA implant for glioblastoma, potent...
A Yale School of Medicine study reveals that recurrent gliomas develop mutations that differ by subtype, suggesting that treatment should target DNA c...
ECGI Holdings has hired IBN to expand investor awareness of its healthcare strategy, which includes building an integrated care ecosystem and pursuing...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical oncology programs to generate more clinically relevant data while red...
VERAXA Biotech is developing antibody-based cancer therapies using its BiTAC platform to enhance treatment selectivity and reduce toxicity, with promi...
Bangladesh's 200,000 suspected measles cases highlight the global risk of falling vaccination rates and the need for sustained public health investmen...
VERAXA Biotech is implementing New Approach Methodologies across its preclinical research programs to generate more clinically relevant data and reduc...
Dr. Mona Mofid's ninth Top Doctor recognition and related awards underscore her consistent excellence in melanoma and medical dermatology, as validate...
Pentixapharm highlights growing international evidence at EANM 2026 supporting Pentixafor PET for non-invasive subtyping of primary aldosteronism, rei...
A small German study showing that a therapeutic vaccine kept two-thirds of brain tumor patients alive eight years after enrollment highlights the grow...
TransCode Therapeutics will present updated Phase 1a clinical data for its lead candidate TTX-MC138 at the ESMO Congress 2026, highlighting progress i...
Creative BioTherapeutics has been named a 2026 Prix Galien USA Best Startup nominee for its work on CBT300, an investigational biologic targeting canc...
A new experimental vaccine has extended survival in glioblastoma patients, particularly those under 65, offering a potential breakthrough in a field t...
As GLP-1 weight-loss medications become more common, patients are seeking treatments like Botox to address facial changes, but experts stress the impo...
Artificial intelligence and next-generation imaging tools are poised to reshape breast cancer detection, enabling earlier diagnosis and personalized s...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform, demonstrating significant tumor regression in a breast cancer...
A UK study reveals a potential method to stop lung cancer before diagnosis by clearing immune fog, though some mice still developed cancer, highlighti...
VERAXA Biotech presented first in vivo proof-of-concept data for its BiTAC-ADC platform at the World ADC Congress, demonstrating significant tumor reg...
A newly identified tumor-suppressive circuit linking SPRED2, p53, miR-506-3p, and KLF4 could offer fresh therapeutic targets for hepatocellular carcin...
A modeling analysis presented at the American Heart Association's Hypertension Scientific Sessions 2026 estimates that expanding high blood pressure t...
Flu cases are increasing across the U.S. earlier than usual, prompting health officials to recommend early vaccination and raising concerns about comm...
Consultwebs is providing a $50 stipend and half-day paid time off to employees who get a mammogram in 2026, aiming to boost early detection and inspir...
Avident Health and Unite for HER have been awarded a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that bridg...
The American College of Radiology now advises all women to undergo a breast cancer risk assessment by age 25, emphasizing earlier and personalized scr...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could accelerate clinical advancement, cut development costs and timelines, and si...
Lantern Pharma (NASDAQ: LTRN) has received regulatory and IRB approvals in Taiwan to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially ...
